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Abstract
The cartilaginous elements forming the pharyngeal arches of the zebrafish derive from cranial neural crest cells. Their proper
differentiation and patterning are regulated by reciprocal interactions between neural crest cells and surrounding
endodermal, ectodermal and mesodermal tissues. In this study, we show that the endodermal factors Runx3 and Sox9b
form a regulatory cascade with Egr1 resulting in transcriptional repression of the fsta gene, encoding a BMP antagonist, in
pharyngeal endoderm. Using a transgenic line expressing a dominant negative BMP receptor or a specific BMP inhibitor
(dorsomorphin), we show that BMP signaling is indeed required around 30 hpf in the neural crest cells to allow cell
differentiation and proper pharyngeal cartilage formation. Runx3, Egr1, Sox9b and BMP signaling are required for expression
of runx2b, one of the key regulator of cranial cartilage maturation and bone formation. Finally, we show that egr1 depletion
leads to increased expression of fsta and inhibition of BMP signaling in the pharyngeal region. In conclusion, we show that
the successive induction of the transcription factors Runx3, Egr1 and Sox9b constitutes a regulatory cascade that controls
expression of Follistatin A in pharyngeal endoderm, the latter modulating BMP signaling in developing cranial cartilage in
zebrafish.
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Introduction
In vertebrates, major parts of the craniofacial skeleton derive
from cranial neural crest cells (cNCCs) that previously migrated
into the pharyngeal arches [1]. cNCCs form bilaterally at the
dorsal edge of the neural tube by the end of gastrulation. Later,
they lose their adhesive properties, separate from the neural tube
and migrate ventrally to finally give rise to cartilage, neurons, glial
cells and pigment cells. Based on their original antero-posterior
position along the posterior brain, cNCCs exhibit a segmental
organization and specification to form three clusters of cells that
migrate and separate into the pharyngeal arches [1]. Each
pharyngeal arch is formed by a mesoderm-derived core embedded
in the neural crest-derived cartilage precursor cells and encased on
the medial side by endoderm and on the lateral side by ectoderm.
Differentiation of cNCCs into mature chondrocytes is con-
trolled by a number of transcription factors. In zebrafish, pre-
migratory cNCCs express tfap2a starting at 12 hours post
fertilization (hpf). tfap2a mutants show defects both in pre-
migratory cNCC specification and in cartilage development [2].
Tfap2a controls expression of the transcription factor Dlx2a,
which is strictly required for correct cNCC migration and survival
[3,4]. Similar to Sox9 in mammals, its co-orthologs Sox9a and
Sox9b are known key regulators of cartilage development in
zebrafish. Sox9 stimulates expression of the cartilage-specific
collagen type 2 gene Col2a1 in mouse (Bell, Leung 1997, Lefebvre
1997), while in zebrafish both sox9a and sox9b are required for
col2a1 expression. However, they play both distinct and over-
lapping functions in zebrafish chondrogenesis [5]. Both factors are
expressed in migratory cranial neural crest cells (cNCC) without
influencing migration of dlx2-expressing cNCC. After migration of
the cNCCs into the pharyngeal arches, sox9a is expressed in
cNCCs under control of dlx2a [4] while sox9b is only expressed in
the pharyngeal endoderm [5]. Mutation of sox9a in the jef mutant
leads to a complete absence of cartilage [6], while sox9b mutation
causes an absence of ceratobranchials and a reduction of the two
most anterior pairs of arches. Sox9a is essential for endochondral
ossification, while sox9b has an additional role in formation of
some dermal bones [5]. In mammals, Sox9 is essential for Runx2b
expression [7,8], but in zebrafish, only Sox9b has this role. Runx2
is an essential transcription factor for osteoblast and early
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chondrocycte differentiation [9] as well as cartilage and bone
development in vertebrates.
In addition to these endogenous patterning cues, cNCCs also
receive external signals from surrounding cells and extracellular
matrix, such as Fgf, BMP and Shh signals [10,11,12,13], which are
absolutely required for pharyngeal cartilage differentiation,
segmentation, and cell survival. Recently, BMP signaling was
shown to promote ventral arch development just after cNCC
migration, however a later function for BMPs in craniofacial
skeleton patterning was also shown [14]. Only the early action
takes place upstream and in parallel to Endothelin 1 signaling. In
zebrafish, lack of pharyngeal endoderm leads to an absence of
pharyngeal cartilage [15,16]. Homozygous casanova (cas) and bonny
and clyde (bon) mutants lack endodermal markers and present severe
cartilage defects [17,18,19,20]. van gogh (vgo) mutants make
pharyngeal endoderm but fail to form pouches, which leads to
an absence of cNCC segmentation into distinct elements [21].
Transplantation of wild-type endoderm into vgo and cas mutants
restores the cartilaginous phenotype [21]. Thus, endoderm
controls the fate of chondrogenic cNCC and has a cell non-
autonomous action on pharyngeal cartilage.
The early growth response (EGR) family contains four highly
conserved zinc finger (C2H2 type) transcription factors that
mediate the cellular response to many stimuli inducing e.g. mitosis,
differentiation and apoptosis [22]. In mice, Egr1 is expressed
during embryogenesis in cartilage, bones, teeth, salivary glands,
nasal glands, developing vibrissa, tendons and skeletal muscles
[23]. In zebrafish, the 3.4 kb long egr1 gene is composed of two
exons and one intron [24]; no transcript was detected by in situ
hybridization before gastrulation [25]. Starting at somitogenesis,
mRNA was observed in posterior adaxial cells of the presomitic
mesoderm until 23 hpf. Various expression domains were also
detected in different brain regions and in the eye. Around 30 hpf,
egr1 expression was observed in the pharyngeal region until at least
48 hpf.
Egr1 is known to play various roles such as tumor promotion in
prostate [26,27], tumor suppressor in various cancers [28,29], cell
growth and differentiation [30] and hematopoietic cell maturation
[31]. Egr1 knockout mice display sterility for both sexes and are
smaller due to defects in adenohypophysis development and
particularly LHb expression [32,33,34]. Egr1 was also shown to
play a role in osteoblast differentiation [35] and is induced in
osteoblasts during microgravity simulation and after mechanical
strain [36]. In rat bone marrow cells, Egr1 was shown to act as
a suppressor of osteoclastogenesis [37]. Egr1 KO mice present
increased bone resorption, a reduced bone mass and an increased
production of the osteoclastogenic cytokine M-CSF (macrophage
Colony-Stimulating Factor) in stromal cells of the bone matrix
[38,39,40]. Egr1 is down-regulated in osteoarthritic cartilage
compared to normal tissue [41] and is required for TNFa
regulation in chondrocytes of catabolic and anabolic genes for the
cartilage extracellular matrix [42]. In zebrafish, knock down of egr1
leads to a reduction of the eye size, while the retina and lens lack
appropriate differentiation [43].
In this study, we report that the transcription factor Egr1 plays
a specific role in pharyngeal cartilage formation during zebrafish
embryogenesis, while it is expressed in pharyngeal endoderm. We
show that Egr1 is part of a regulatory cascade, together with the
endodermal factors Runx3 and Sox9b, that suppresses expression
of follistatin A (fsta), a known BMP antagonist. We also show that
BMP signaling is required around 30 hpf in the neural crest cells
for runx2b expression in chondrocytes and proper pharyngeal
cartilage formation, while BMP signaling is absent in the
pharyngeal region upon egr1 knock-down.
Materials and Methods
Fish and Embryo Maintenance
Zebrafish (Danio rerio) were reared in a recirculating system from
Techniplast, Italy at a maximal density of 7 fish/l. The water
characteristics were as follows: pH=7.4, conductivi-
ty = 500 mScm-1, temperature = 28uC. The light cycle was con-
trolled (14 h light, 10 h dark). Fish were fed twice daily with dry
powder (ZM fish foodH) with size adapted to their age, and once
daily with fresh Artemia salina nauplii (ZM fish foodH). Larvae aged
less than 14 days were also fed twice daily with a live paramecia
culture. Wild type embryos from the AB strain were used and
staged according to Kimmel [44]. The transgenic line
Tg(hsp70l:dnBmpr-GFP) [45] was obtained from the ZIRC (Eugene,
Oregon, USA).
Breeding: the day before breeding, 2 males and 2 females were
placed in breeding tanks out of the recirculating system, with an
internal divider to prevent unwanted mating. On the day of
breeding, fish were placed in fresh aquarium water and the divider
was removed to allow mating. Eggs were collected every 30
minutes and raised in E3 (5 mM Na Cl, 0.17 mM KCl, 0.33 mM
CaCl2, 0.33 mM MgSO4, 0.00001% Methylene Blue).
All experiments and the entire study were evaluated by the
Ethical Committee of the University of Liege, Belgium and
accepted under the file numbers 377, 568 and 1074.
Loss of Function and Rescue Experiments
Morpholino oligonucleotides (MO) were synthesized by Gene
Tools (Philomath, OR, USA) and are complementary to the 59
sequence near the translation start site or to the splice junctions.
MO stock solutions were prepared as suggested by Gene Tools.
Tetramethylrhodamine dextran (Invitrogen, Belgium) was added
at a concentration of 0.5% to sort correctly injected embryos a few
hours after injection. The morpholino sequences are as follow:
MO splicing egr1: GGATTTAGTGCTTACCTCCAGCAAG.
MO translation egr1: TGCAGCCATCTCTCTG-
GAGTGTGCT.
MO translation runx3: TGCTCGGGTCTACGGGAA-
TATGCA [46].
MO translation fst1a: CTGACGTTTAGCATCCTTAG-
CATG [47].
MO standard control: CCTCTTACCTCAGTTACAATT-
TATA (Gene-ToolsH).
An egr1 cDNA fragment starting at the ATG start codon and
spanning the entire coding region was obtained by PCR-
amplification from the cDNA clone [25] and inserted into
pCRII-TOPO and a SV40 polyadenylation signal sequence was
added at the 39 end. egr1 mRNA was synthesized using mMessage
mMachine Sp6 (AmbionH) and injected alone or co-injected with
a morpholino at the one-cell stage with a microinjector (Nar-
ishigeH).
Efficiency of the splicing morpholino MOegr1 spl was examined
by RT-PCR using SuperScriptH from Invitrogen (Gent, Belgium).
mRNA of 50 injected embryos was extracted for each experiment.
The primers used were: Zf-Egr1 forward: 59-CAGTTTGAT-
CACCTTGCTGG-39; Zf-Egr1 reverse: 59-GGAAGACGTG-
GAAGAGGAAG-39.
Whole-mount in situ Hybridization and
Immunohistochemisrty
Injected embryos for in situ hybridization were raised in
presence of 0.003% of 1-phenyl-2-thiourea until the desired stage,
fixed overnight in 4% of PFA at 4uC and stored in 100% methanol
at 220uC until use. Visible in situ hybridizations (ISH) were
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performed as described [48]. Fluorescent labeling was performed
as described [49,50].
Whole-mount fluorescent immunohistochemistry was described
in [51]. We used the following antibodies: polyclonal rabbit anti-
phospho-Smad (1:200, Cell SignalingH), polyclonal mouse anti-
GFP (1:250, RocheH) and fluorescently conjugated Alexa anti-
bodies (Molecular ProbesH).
Image Acquisition
Pictures of visible in situ hybridization were taken by NikonH
Eclipse 90i microscope and NIS-Elements microscope imaging
software. Fluorescent images were acquired with a LeicaH SP2
confocal microscope.
Alcian Blue Staining
Cartilage was stained with Alcian Blue 8 GX (SigmaH). Four
days old embryos were fixed in PFA 4% for 2h at room
temperature, rinsed with PBST and finally stained overnight with
10 mM Mg Cl2/80% ethanol/0.04% Alcian Blue solution.
Embryos were rinsed with 80% ethanol/10 mM MgCl2. Pig-
ments were bleached in H2O2 3%/KOH 0,5% for 1 h. 25%
glyce´rol/0,1% KOH, 50%Glycerol/0,1% KOH.
Heat Shock Conditions
Transgenic embryos hsp70l:dnBmpr-GFP [45] were heat shocked
at desired stages by placing them into a water bath for 30 minutes
at 37uC and afterward placed back at 28uC. Two hours after the
heat shock, the embryos were screened for GFP fluorescence.
Embryos not expressing GFP were used as non-transgenic
controls.
Dorsomorphin Treatments
10 mM stock solution of dorsomorphin (CalbiochemH) was
diluted in DMSO (CalbiochemH). Embryos at desired stage were
placed into multiwell plates with dorsomorphin diluted in E3
rearing medium at the desired concentration during a specific time
period. DMSO alone was used as control. Embryos were then
rinsed several times with E3, raised in E3 and finally fixed at the
desired stage.
Results
Egr1 is Essential for Zebrafish Pharyngeal Cartilage
Development
To gain insights into an embryonic role of Egr1 in cartilage
formation, we depleted Egr1 in developing zebrafish embryos by
microinjecting fertilized embryos with morpholinos (MO) directed
against egr1 transcripts or against a control sequence (MOcon).
Two different morpholinos against egr1 were used, one inhibiting
egr1 splicing (MOegr1 spl) and the other preventing translation of
egr1 mRNA (MO egr1 tr). Injection of MO egr1 spl efficiently
inhibited egr1 splicing in embryos, as judged by RT-PCR of 2
days post fertilization (dpf) embryos (Fig.1I), whereas injection of
MOcon did not.
Pharyngeal and cranial cartilages were stained with Alcian Blue
in 4 dpf embryos. Remarkably, in embryos injected with 8 ng of
MOegr1 tr, branchial cartilages were completely absent, while
Meckel’s cartilage and the palatoquadrate were significantly
reduced and the ceratohyal and hyosymplectic misshapen (104/
119; 89%) (Fig.1A,B). A similar phenotype was obtained when
4 ng MO egr1 spl was injected, with 87% (120/137) of injected
individuals failing to develop branchial cartilages and displaying
reduction and malformation of the two first pharyngeal arches
(Fig.1C). Axis modification of the hyosimplectics and ceratohyals
was also observed in a lateral view (Fig.1B,C,D,E). These results
indicate that egr1 may be required for craniofacial development in
zebrafish.
To test the specificity of the observed phenotype, we co-injected
egr1 mRNA together with MO egr1 or MOcon. Co-injection of
75 pg of egr1 mRNA together with 8 ng MOegr1 tr rescued the
development of pharyngeal and cranial skeleton in 87% of co-
injected embryos (43/49; 87%) (Fig.1G), while branchial arch
development in 4 ng MOegr1 spl injected embryos was also
rescued by egr1 mRNA expression (Fig.1H). In contrast, injection
of 75 pg egr1 mRNA alone had only slight effects on formation of
the cartilaginous elements (Fig.1F). Thus, for all subsequent
experiments, we used 4 ng of MO egr1 spl. We conclude that Egr1
is required for pharyngeal cartilage development in zebrafish.
Egr1 Regulates Late Chondrogenesis in Pharyngeal
Skeleton
To specify the function of Egr1 during cartilage development,
we assayed the expression of neural crest cell and cartilage markers
in egr1 morphant embryos by in situ hybridization. Expression of
early neural crest markers ap2a3 was not affected in egr1
morphants at 24 hpf (Fig.2A,F). In addition, the expression of
dlx2a, expressed in a subset of pre- and post-migratory cNCC that
give rise to pharyngeal cartilage [52,53] was not affected at 24 and
48 hpf in egr1 morphants (Fig.2B,C,G,H). This indicates that Egr1
is not required for formation of cNCC or their migration into
pharyngeal arches.
Proper chondrocyte stacking in cartilage requires the expression
of Sox9a in these cells [6]. In egr1 knock-down embryos, sox9a
expression in pharyngeal chondrocytes remained unaffected at
48 hpf compared to control embryos (Fig.2D,I), indicating that the
initial steps of chondrocyte differentiation are not affected
following egr1 knock-down.
Runx2b is a transcription factor known to play a key role in
chondrocyte maturation and is expressed in mesenchymal
cartilage condensations in the viscerocranium starting at 40 hpf
[54,55] and, at later stages in endochondral and intramembranous
bone elements. In contrast to the earlier marker sox9a, expression
Figure 1. Knock-down of egr1 severely affects head cartilage formation at 4 dpf. (A–I) Head cartilages were stained with Alcian Blue in
morpholino treated larvae at 4 dpf; ventral (A–C) and lateral (D,E) views are shown. (A,D) control 8 ng MOcon treated larvea. (B) 8 ng translation
MOegr1 injected larveas display an absence of ceratobranchials and a reduction of size and mis-shaping of pharyngeal cartilage compared to controls
(A); (C,E) 4ng splicing MOegr1 injected embryos display similar cartilage defects than 8 ng translation MOegr1 (B). (F) Ectopic expression of Egr1 does
not significantly affect cartilage development. (G) Rescue of 8 ng MOegr1 tr treated larvae restores all cartilaginous elements of the viscerocranium.
(H) A complete restoration of all cartilage elements is obtained by rescuing 4 ng splicing MOegr1 injected larvae. Meckel’s cartilage (m),
palatoquadrate (pq), ceratohyal (ch) and hyosymplectic (hs), ceratobranchials 1 to 5 (cb1-5). (I) Agarose gel electrophoresis analysis of RT-PCR
products from mRNA of injected embryos: 1) control mRNA; 2) mRNA of embryos injected with MOcon 4ng and without reverse transcriptase; 3)
mRNA of embryos injected with MOegr1 spl 4 ng and without reverse transcriptase; 4) cDNA of embryos injected with MOcon 4 ng. Presence of
a band at 269 bp, intron has been spliced properly; 5) cDNA of embryos injected with MOegr1 spl 4 ng. Presence of a band at 966 bp indicating that
intron has not been properly spliced. However a residual band at 269 bp reveals that the mRNA has been partially spliced; 6) and 7) cDNA of MOcon
4 ng and MOegr1 spl 4 ng injected embryos that have not undergone the PCR step; 8) molecular weight marker.
doi:10.1371/journal.pone.0050140.g001
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of runx2b was abolished in 40 hpf (247/263, 93%) and 48 hpf
(621/647, 95%) egr1 morphants (Fig.2E,J). At 48 hpf, no
expression was detected in the mandible, the hyoid nor in the
ceratobranchials, a weaker expression was observed in the ethmoid
plate while interestingly the expression remained normal in the
cleithrum, an intramembranous bone. The specificity of this effect
was confirmed by co-injection of 80 pg of egr1 mRNA to 4 ng of
MO egr1 spl (Fig.2K), revealing that exogenous Egr1 was able to
rescue runx2b expression in the head cartilage (265/297, 89%).
We conclude that egr1 expression is dispensable for early
specification and migration of cNCCs, but is required for proper
late chondrogenesis in pharyngeal arches.
Egr1 is Expressed in Pharyngeal Endoderm and Oral
Epithelium
To better understand the cartilage defects observed in the
absence of Egr1, we sought to determine the egr1 expression
pattern in the developing pharyngeal region. Whole-mount in situ
hybridization against egr1 confirmed its expression in the
pharyngeal region starting at 30 hpf and persisting until at least
48 hpf (Fig.3A,D and [25]). At 48 hpf, egr1 mRNA was detected in
oral epithelium (Fig.3D) and in the endodermal pouches of the
arches. This expression is observed until at least five days of
development (Fig.3I,J). Expression in pharyngeal cartilage con-
densations was never observed.
To determine precisely in which tissue egr1 is expressed, we
performed double fluorescent in situ hybridizations at different
stages of embryonic development using various markers for
specific tissues. At 48 hpf, we performed a double hybridization
for egr1 (in FITC, green) and fli1 (in Cy3, red), which is expressed
in pre-cartilage condensations and endothelium [2]. In confocal
microscopy, the most lateral optical (longitudinal) sections reveal
expression of fli1 in the cartilage condensations while egr1
expression is located in stripes separating cartilages (Fig.3B, Movie
S1). In more central sections, egr1 mRNA is seen in the medial
pharyngeal endoderm (Fig.3C, Movie S1). At three days of
development, by comparing the expression of runx2b (Fig.3E), dlx2a
(not shown) and sox9a (Fig. 3F, Movie S2) in the pharyngeal
cartilage condensations with that of egr1, we did not observe any
colocalization. We can clearly see that at this stage egr1 is
expressed in the pharyngeal endoderm and pouches that surround
the pharyngeal cartilage. Furthermore, we observed co-expression
of egr1 with that of the endodermal marker sox9b at three days in
pharyngeal endoderm and pouches (Fig. 3G, Movie S3). At 4 dpf,
the egr1 expression domain is clearly surrounding the fli1 domain
in cartilage (Fig.3H, Movie S4). No colocalization was observed
between egr1 and fli1 at any stage. To confirm the expression of
egr1 in the pharyngeal endoderm, we also carried out in-situ
hybridization for egr1 in casanova (cas) mutant embryos, devoid of
all molecular endodermal markers [17]. In wild-type siblings (Fig.
S1A,C), egr1 transcripts were observed at 48 hpf in the pharyngeal
region as well as in different brain regions and in the heart. In
contrast, in 48 hpf homozygous cas embryos (Fig. S1B,D), no egr1
expression was observed in the pharyngeal region (126/126,
100%), while expression is maintained in the brain, the duplicated
hearts and increased in the fin buds.
We conclude that egr1 is expressed in the pharyngeal endoderm
of developing zebrafish embryos.
Egr1 is Required for Pharyngeal Endoderm Expression of
sox9b
The casanova mutant, devoid of endodermal tissue and known to
be deficient in cartilage formation, [46] fails to express runx2b at
48 hpf ([46] and data not shown) similar to egr1 morphants. Given
Figure 2. Only late chondrogenic and osteogenic marker genes display decreased expression in egr1 morphants between 24 and
48 hpf. In situ hybridization was performed at the indicated stages for various cartilage markers, lateral views, anterior to the left. Scale bars 100 mm.
(A–E) 4 ng MOcon treated control embryos, (F,G,H,I,J) 4ng splicing MOegr1 injected embryos and (K) rescue. (A,F) At 24 hpf, ap2a3 expression in
cranial neural crest cells (cNCC) is not altered in morphants. (B,C,G,H) cNCC marker dlx2a is normally expressed in egr1 morphants (G,H) compared to
control embryos (B,C) at 24 and 48 hpf. (D,I) Expression of the essential chondrogenic gene sox9a is not changed at 48 hpf by egr1 knock-down.
(E,J,K) At 48 hpf, runx2b transcripts are absent in pharyngeal cartilage precursor cells in 4 ng MOegr1 spl embryos. Expression of runx2b is maintained
in the cleithrum (cl) and ethmoid plate (ep). (K) Rescue by injection of 80 pg mRNA egr1 restores all runx2b expression domains at 48 hpf. Otic vesicle
(ov), mandible (m), ceratohyal (ch), hyosymplectic (hs), ceratobranchial pairs 1 to 5 (cb1-5), cleithrum (cl), ethmoid plate (ep), stream of cNCCs (S1–S3).
doi:10.1371/journal.pone.0050140.g002
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the importance of pharyngeal endoderm for craniofacial cartilage
development, we wished to test the role of Egr1 in this tissue.
To determine whether Egr1 is required for endoderm
formation, we tested whether pharyngeal endoderm is still present
in egr1 morphants. By in situ hybridization, expression of the
Figure 3. Expression of egr1 in the pharyngeal region between 30 hpf to 5 dpf is restricted to endoderm and epithelium. Lateral (A–
G,I) and ventral (H,J) views, anterior to the left. Scale bars 100 mm. Images of double in situ hybridizations were taken by confocal microscopy and
pictures of individual Z-sections are shown. (A) egr1 transcripts are observed in the pharyngeal region starting at 30 hpf in endoderm. (B,C) At 48 hpf,
double in situ hybridization for egr1 (green) and fli1 (red); egr1 transcripts are localized in pharyngeal endoderm and do not colocalize with fli1 mRNA
in pharyngeal cartilage precursor cells. (D) egr1 is expressed in pharyngeal endoderm. (E–G) At 3 dpf, egr1 (green) does not colocalize with runx2b
(red) (E) or sox9a (red) (F) in cartilage, while (G) egr1 (green) mRNAs colocalize with those for the pharyngeal endoderm marker sox9b (red). (H) At
4 dpf, egr1 (green) is never expressed in cells in pharyngeal cartilage precursor cells expressing fli1 (red). (I) Expression of egr1 at 4 dpf in pharyngeal
endoderm. (J) At 5 dpf, egr1 is still expressed in pharyngeal endoderm (stars) and not in pharyngeal cartilage. Pharyngeal endoderm (pe), cranial
neural crest cells (cNCC).
doi:10.1371/journal.pone.0050140.g003
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endodermal marker nkx2.3 was still present in egr1 morphants at
48 hpf, although some alterations in the precise shape of the
pouches are observed relative to control embryos, probably
reflecting the described defects in cNCC cells (Fig.4A,D).
Similarly, sox17-GFP transgenic embryos expressing GFP in the
entire endoderm, previously injected with MOegr1 spl morpholino
display a normal pharyngeal GFP expression until 72 hpf
(Fig.4B,E). Thus, Egr1 depletion does not prevent formation of
the pharyngeal endoderm.
At stages beyond 26 hpf, expression of the Sox9b transcription
factor is localized in pharyngeal epithelium and endoderm; this
factor indirectly regulates runx2b expression in the neighboring
perichondrium and chondrocytes and controls chondrocyte pro-
liferation, cell death and patterning [5]. In homozygous sox9bb971
mutants, cranial runx2b expression is only maintained in the
cleithrum (84/88, 95%), reminiscent of the situation observed in
egr1 morphants.
Knowing that egr1 is expressed in pharyngeal endoderm, we
investigated potential regulatory connections between the sox9b
and egr1 genes. At 42 hpf, egr1 morphants do not express sox9b in
the pharyngeal pouches and its expression in the brain is altered
(156/171, 91%) (not shown). At 48 hpf, sox9b mRNA is still absent
in the branchial arches of egr1 morphants, while a decreased
expression relative to controls is observed in the two first
pharyngeal arches (432/462, 93%) (Fig.4C,F). The observed
decreased sox9b expression was rescued by injecting 80 pg of egr1
mRNA along with 4 ng of egr1 splicing morpholino, showing its
specificity for Egr1 knock-down (264/311, 84%) (Fig.4G).
Conversely, in sox9b mutant (sox9bb971) embryos, the egr1
expression pattern remains intact in the pharyngeal endoderm
and epithelium as compared to wild type control siblings
(Fig.4H,I). Our results demonstrate that Egr1 is required for sox9b
expression in pharyngeal endoderm.
Runx3 Controls Cartilage Development by Regulating
egr1 and sox9b Expression in Pharyngeal Endoderm
In zebrafish, runx3 is another gene expressed in pharyngeal
endoderm and required for runx2b expression in the ventral
pharyngeal chondrocytes [46], similar to the egr1 and sox9b genes.
Therefore, we decided to investigate the contribution of the runx3
gene to the regulatory cascade in pharyngeal endoderm by
performing epistasis experiments.
By in situ hybridization, we showed that runx3 expression at
48 hpf was similar in endodermal pouches of egr1morphants (102/
106, 96%) to that in control embryos (Fig.5A,B). Conversely, to
investigate the function of Runx3 in egr1 and consequently also
sox9b and runx2b expression, we performed runx3 depletion using
well established morpholino-mediated knock-down [46]. As
expected, injection of 2 ng of runx3 morpholino into wild-type
eggs resulted in a complete absence of viscerocranium and the
anterior part of the neurocranium, as revealed by Alcian Blue
cartilage staining at 4 dpf (123/137, 92%) (Fig.5C,D). We also
confirmed that runx3 knock-down disrupts runx2b expression in
pharyngeal arch mesenchyme and that only a small expression
remains in basicranial anlagen at 48 hpf (251/273, 91%)
(Fig.5E,F). Importantly, runx3 morpholino injected embryos
completely lost egr1 transcripts in the pharyngeal region, while
these were maintained in the telencephalon at 48 hpf compared to
Figure 4. Egr1 is required for expression of sox9b in pharyngeal endoderm. Endodermal gene expression by in situ hybridization
(A,C,D,F,G,H,I) or in living transgenic embryos (B,E) in control embryos (A–C,H), egr1 morphants (D–F), rescued embryos (G) and sox9b mutants (I) at
48 hpf. Lateral views, anterior to the left. Scale bars 100 mm. (A,D) nkx2.3 expression is not altered in 4 ng MOegr1 spl injected embryos. (B,E) In living
sox17:GFP transgenic embryos, the transgene is correctly expressed in egr1 morphants. (D,F,G) The endodermal marker sox9b is not expressed in the
pharyngeal endoderm in 4 ng MOegr1 spl injected embryos, but its expression is rescued upon co-injection of 80 pg egr1 mRNA and spl 4 ng
MOegr1. (H, I) In homozygous sox9b2/2 embryos, egr1 transcripts are still observed in the pharyngeal endoderm like in the wild-type or heterozygous
sox9b+/2 embryos. Pharyngeal endoderm (pe), otic vesicle (ov).
doi:10.1371/journal.pone.0050140.g004
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control morpholino-injected siblings (310/347, 89%) (Fig.5G,H).
Consistent with our previous observations, sox9b expression in
pharyngeal endoderm was also disrupted at 48 hpf in runx3
morphants (172/198, 86%) (Fig.5I,J). Finally, nkx2.3 expression
was maintained (Fig.5K,L) indicating that the endoderm itself was
present.
When we tested the specificity of the effects observed in runx3
morphants by alcian blue staining at 4 dpf, we observed that co-
injection of runx3 mRNA caused a partial rescue in 89% of the
larvae (Fig.6A,B,D), while runx3 mRNA alone had no effect
(Fig.6C). As shown before, injection of egr1 mRNA had no effect
(Fig.6E), however its co-injection with MO runx3 caused a partial
rescue of the anterior part of the viscerocranium in 62% of the
larvae (Fig.6F), indicating that Runx3 is indeed acting through
activation of egr1 expression.
In conclusion, our results show that in pharyngeal endoderm
Runx3 is required for egr1 expression, which in turn is required for
sox9b expression and, finally Sox9b presumably triggers an
extracellular signal leading to runx2b expression in post-migratory
cNCC and chondrogenesis.
Egr1 Down Regulates Follistatin a Expression in
Pharyngeal Endoderm and Cartilage
To determine which extracellular signal is controlled by the
endodermal regulatory cascade, we decided to analyze different
candidate ligands of the HH and BMP signaling pathways in egr1
morphants. Shh is expressed in pharyngeal endoderm [15], its
expression is not affected in egr1 morphants compared to control
embryos at 48 hpf. Among the BMP factor family, bmp2a, bmp2b,
bmp4, bmp5 and bmp7 are all expressed in pharyngeal endoderm.
By in situ hybridization in Egr1 depleted embryos, no significant
alteration of expression was observed in the pharyngeal region for
any of these genes (data not shown).
The gene coding for the secreted TGFß/BMP antagonist
follistatin A (Fsta) is expressed in presumptive cephalic mesendo-
derm at 8 hpf [47,56] and at later stages in arch vasculature and
skeleton [57,58]. In homozygous casanova mutants, devoid of
endoderm, sox9b mRNA was undetectable (92/96, 95%) (Fig.
S2A,B) and fsta expression is abolished (57/61, 93%) (Fig. S2C,D)
in the branchial region at 48 hpf, confirming the expression of
both genes in pharyngeal endoderm or at least the requirement of
this tissue for their expression in this region.
In egr1 morphants, a clear over-expression of fsta (274/302,
90%) relative to controls was observed at two days of development
(Fig.7A, B). The fsta expression domain is more intense and
extended in MOegr1-injected relative to MOcon-injected embry-
os, indicating that Egr1 is required for inhibition of fsta expression
in wild type embryos. Similarly, embryos depleted of Runx3 by
microinjection of MOrunx3 (157/170, 92%) (Fig.7C,D), or of
Sox9b in the homozygous sox9bb971I mutant (77/79, 97%)
(Fig.7E,F) displayed a dramatic increase of fsta expression and
an extension of its expression domain as compared to wild type
embryos. Thus, depletion of any of the endodermal transcription
factors leads to increased fsta expression.
To further characterize a putative function of Follistatin A in
cartilage development, we decreased its expression by injecting
a splicing morpholino against fsta [47]. Injection of 6 ng of MOfsta
spl resulted in 85% (86/101) of 4 dpf larvae displaying clearly
increased cartilage elements compared to the controls (Fig.7G,H),
Figure 5. Runx3 is required for pharyngeal egr1 and sox9b
expression at 48 hpf. Lateral views of in situ hybridizations (A,B,E–L)
with indicated markers and ventral views of Alcian Blue stained
embryos (C,D), anterior to the left. Scale bars 100 mm. (A,B) Endodermal
runx3 expression in the pharyngeal region is not altered in 4 ng MOegr1
spl morphants. (C,D) runx3 knock-down using 2 ng MOrunx3 tr leads to
total absence of viscerocranium and the anterior neurocranium (D)
compared to control (C) embryos. (E,F) runx3 morphants do not express
runx2b in pharyngeal cartilage precursor cells. (G,H) runx3 morphants
do not express egr1 transcripts in pharyngeal endoderm. (I,J) The
endodermal marker sox9b is absent in pharyngeal endoderm when
runx3 expression is blocked. (K,L) runx3 knock-down does not affect
expression of pharyngeal endodermal marker nkx2.3 at 48 hpf.
Trigeminal ganglia (tg), pharyngeal endoderm (pe), cleithrum (cl),
Meckel’s cartilage (m), palatoquadrate (pq), hyosymplectic (hs),
ceratohyal (hs), ceratobranchials 1 to 5 (cb1-5), ethmoid plate (ep), otic
vesivle (ov).
doi:10.1371/journal.pone.0050140.g005
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showing that Follistatin A indeed plays an inhibitory role on the
formation of head cartilage.
Taken together, these results indicate that the endodermal
cascade of transcription factors Runx3, Egr1 and Sox9b is
required to reduce the level of fsta expression in the pharyngeal
region.
BMP Signaling is Required for Pharyngeal Cartilage
Formation and runx2b Expression in Cartilage
In vertebrates, the BMP pathway is known to play an essential
role in skeletogenesis [12], but also many early developmental
processes such as gastrulation or neurulation [59]. In particular,
BMP signaling directs ventral patterning of the viscerocranium
before 24 hpf [14]. Most of the factors investigated here are
expressed in the pharyngeal region at stages beyond 24 hpf and
the defects caused by their depletion are also observed at these
later stages. To investigate whether Egr1 or FstA might be
required for early ventral patterning of the pharyngeal arches, we
tested the expression of the ventral markers hand2 and edn1 at
24 hpf in egr1 and fsta morphants. Expression of both ventral
markers was maintained in the microinjected embryos (Fig.8A–F),
indicating that dorso-ventral patterning is not affected by depletion
of Egr1 or FstA. We also showed that the weak fsta expression at
24 hpf is not affected in egr1 morphants (Fig.8G,H), further
supporting the notion that the endodermal regulatory cascade acts
beyond 24 hpf. Similar results were obtained at 30 hpf (data not
shown).
To assess the role of BMP signaling in head cartilage formation
at later stages of development without affecting earlier processes,
we investigated the effects of dorsomorphin, a selective inhibitor of
ALK2, BMPR-IA and BMPR-IB signaling and of BMP-induced
Smad1/5/8 phosphorylation [60] at different stages beyond
24 hpf. The effects on cranial cartilage formation were analyzed
by Alcian blue staining at 4 dpf and the treated larvae were
classified according to the extent of the defects seen in cartilage
formation (Fig.9A–C). Type 1 was considered as wild-type
cartilage morphology, type 2 larvae displayed a severe reduction
or absence of the five pairs of branchial arches and a malformation
and reduction of the first two pairs of pharyngeal arches (mandible
and hyoid). Finally, type 3 larvae are characterized by a complete
absence of pharyngeal arches (viscerocranium) and severe re-
duction of the neurocranium.
Treatment of embryos with 200 mM dorsomorphin between 24
and 30 hpf resulted in 70% (138/197) of type 1 larvae, 23% (47/
197) of type 2 larvae and 6% (12/197) of larvae with a complete
loss of viscerocanium (type 3), while after treatment between
27 hpf and 37 hpf, we observed only 6% (14/231) of type 1 larvae,
77% (177/231) of type 2 larvae and finally 17% (40/231) of type 3
larvae (Fig.9D). Treatment between 29 hpf and 45 hpf resulted in
85% (218/257) of type 2 larvae and 15% (39/257) of type 3 larvae.
In contrast, dorsomorphin treatment performed between 48 hpf
and 54 hpf led to 88% (174/198) of the drug treated larvae
displaying a type 1 cartilage morphology and only 12% (24/198)
with a type 2 cartilage morphology. These results clearly confirm
that the BMP pathway is required for proper cartilage formation
in zebrafish at these later stages, comparison of the different
experiments reveals that the most crucial period lies between
27 hpf and 37 hpf.
To confirm this requirement for BMP signaling at late stages,
we also used an inducible dominant negative BMP receptor-GFP
transgenic line (hsp70l:dnBmpr-GFP)w30. We performed a heat
shock at 37uC during 30 minutes at 29 hpf and compared the
head cartilage at 4 dpf of the transgenic larvae to that of their non-
transgenic siblings (Fig.9E). While 92% (140/152) of control larvae
formed a perfectly normal type 1 cartilage, indicating that the heat
shock itself had no effect, the transgenic larvae (positive for GFP
expression) producing the active dominant negative BMP receptor
presented a clear alteration of chondrogenesis, with 62% (106/
171) belonging to type 2 cartilage morphology, 24% (41/171) type
1 cartilage morphology and 14% (147/171) type 3 cartilage
morphology. When heat shock on (hsp70l:dnBmpr-GFP)w30 was
Figure 6. Runx3 depleted embryos can be rescued by runx3 and
egr1 mRNA. (A–F) Head cartilages were stained with Alcian Blue in
morpholino treated larvae at 4 dpf; ventral views are shown. (A) MOcon
2 ng injected larvae. (B) MOrunx3 2 ng injected larvae do not develop
viscerocranium. (C) 100 pg of runx3mRNA do not affect 4 dpf old larvae
cartilage morphology. (D) Injection of 100 pg runx3 mRNA rescues 89%
of MOrunx3 2 ng injected eggs. (E) 80 pg of egr1 mRNA. (F) Injection of
80 pg egr1 mRNA rescues 62% of MOrunx3 2 ng injected eggs.
doi:10.1371/journal.pone.0050140.g006
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performed after 48 hpf, almost all larvae presented normal
cartilage (123/129, 95%) (type 1). These results clearly confirm
that BMP signaling is required for pharyngeal cartilage formation
between 27 hpf and 37 hpf.
The cartilage defects observed upon BMP inhibition are quite
similar to those obtained in egr1 and runx3 morphants or sox9b
mutants. Therefore, we also analyzed runx2b expression at 48 hpf
in embryos treated with 200 mM dorsomorphin between 27 hpf
Figure 7. Expression of fsta is increased in runx3 and egr1morphants and sox9bmutants. Lateral views of in situ hybridizations, anterior to
the left. Scale bars 100 mm. (A–F) Compared to controls or wild-type embryos, expression of fsta is up-regulated in egr1 morphants (A,B), runx3
morphants (C,D), and homozygous sox9b mutants (E,F) at 48 hpf. pharyngeal endoderm (pe). (G,H) 4 dpf Alcian Blue stained larvae injected with
MOcon 6 ng (K) and MOfsta 6ng (L). Knock-down of fsta causes a hyperplasia of the viscerocranium. Meckel’s cartilage (m), ceratohyal (ch),
ceratobranchials 1 to 5 (cb1-5).
doi:10.1371/journal.pone.0050140.g007
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and 37 hpf (Fig.9F–H). Half of the treated embryos did not
express runx2b in pharyngeal arches (285/543, 52%), while it
remained expressed in the ethmoid plate and cleithrum. Upon
heat shock of (hsp70l:dnBmpr-GF)w30 transgenic animals at 29 hpf,
we observed the same percentage (33/66, 50%) of embryos
expressing runx2b only in the cleithrum at 48 hpf.
Taken together, these observations indicate that inhibition of
BMP signaling between 29 and 37 hpf causes cartilage defects at
4 dpf and prevents runx2b expression at 2 dpf, similar to the defects
observed upon blocking of the Runx3-Egr1-Sox9b cascade in the
endoderm.
Egr1 is Required for BMP Signaling in the Pharyngeal
Region
Finally, we determined whether the Runx3-Egr1-Sox9b cascade
is required to maintain normal BMP signaling in cartilage
precursors by reducing Fsta signaling in the pharyngeal arches.
To this end, we performed double fluorescent immunohistochem-
istry using anti-phospho-Smad1/5/8 and anti-GFP antibodies on
fli1-GFP embryos. We used fli-GFP expressing embryos in order to
visualize the cNCC through the presence of GFP. The embryos
were injected with a control morpholino or the egr1 splicing
morpholino and fixed at 32 hpf to perform immunohistochemistry
(Fig.10A–F).
By confocal analysis, we detected the presence of phospho-
Smad1/5/8 in the entire pharyngeal arch region including the
fli1-expressing cranial cartilage precursor cells in 32 hpf old
MOcon embryos, indicating that BMP signaling is active at 32 hpf
in control embryos (Fig.10A–C). When we analyzed egr1
morphants, no phospho-Smad1/5/8 was detected in the pharyn-
geal region (Fig.10D–F). In addition, we could also confirm that
fli1-GFP expressing cNCCs are disorganized in egr1 morphants
compared to controls. Altogether, our results demonstrate that
Egr1 and the regulatory cascade Runx3/Egr1/Sox9b/Fsta
expressed in the pharyngeal endoderm is absolutely required for
BMP activation in cartilage around 29 hpf.
Discussion
Pharyngeal Endoderm Hosts a Regulatory Cascade of
Transcription Factors Required for Formation of the
Viscerocranium
In this study, we identified a regulatory cascade composed of
three transcription factors: Runx3, Egr1 and Sox9b occurring
beyond 24 hpf in zebrafish pharyngeal endoderm. This cascade is
required for inhibition of fsta expression, coding for a known
secreted BMP inhibitor, thereby allowing proper BMP signaling to
the developing cNCCs.
We have shown that all three factors are coexpressed in
pharyngeal endoderm starting at about 30 hpf and that each of
them is absolutely required for pharyngeal cartilage formation.
These results are in agreement with previous studies concerning
the function of Sox9b and Runx3 in zebrafish. Expression of runx3
was found in pharyngeal pouches at 2 dpf and in endodermally
derived oral epithelium at 3 dpf [46]. Our own loss of function
experiments confirmed that runx3 morphants nearly completely
Figure 8. egr1 and fsta knock-down do not affect ventralisation of cranial neural crest cells. In situ hybridization was performed at 24 hpf,
lateral views, anterior to the left. Scale bars 100 mm. (A,D,G) MOcon 4 ng, (B,E,H) MOegr1 4 ng and (C,F) MOfsta 6 ng. No modification in the
expression of markers hand2, edn1 and fsta was observed in MOegr1 4 ng or MOfsta 6 ng injected embryos compared to control.
doi:10.1371/journal.pone.0050140.g008
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lack head cartilage [46] and lost runx2b expression in pharyngeal
cartilage. Similarly, sox9b is expressed (starting at 26 hpf) in
pharyngeal endoderm and sox9b mutants or morphants display
a dramatic reduction of pharyngeal cartilage at 4 dpf and a lack of
runx2b expression at 48 hpf, while exogenously expressed Sox9b
partially rescued the mutant phenotype [5]. Thus, at later stages
endodermal Runx3 and Sox9b regulate cartilage and bone
development by indirectly controlling runx2b expression in cNCC
cells.
Here, we introduce a new player by showing that the
endodermal transcription factor Egr1 is required for cartilage
formation and expression of sox9b in endoderm and runx2b in
cNCCs. Expression of egr1 in endodermal pouches was deduced
from single and double fluorescent in situ hybridization experi-
ments, co-expression of egr1 with cNCC markers such as dlx2a (not
shown) or sox9a was never observed. The complete absence of egr1
mRNA in the pharyngeal region of casmutants, lacking endoderm,
further supports this conclusion. The defects were observed
following gene knock-down using translation or splicing morpho-
linos and the specificity of these defects for Egr1 depletion was
shown by the rescue experiments.
Additional experiments revealed that Runx3 depletion led to
decreased expression of both egr1 and sox9b, while runx3 expression
was not affected in egr1 morphants or sox9b mutants. Egr1
depletion decreases sox9b expression only, while conversely egr1
expression is not affected in sox9b mutants. Finally, sox9b mutants
display normal expression of egr1 and runx3. We further show that
the defects observed in runx3 morphants can be partially rescued
by expression of exogenous runx3 or egr1 mRNA, clearly indicating
that Runx3 is located upstream of Egr1. Taken together, these
Figure 9. BMP signaling is required between 27 and 37 hpf for runx2b expression and head cartilage development. (A–E) Cartilage
was stained with Alcian Blue in 4 dpf larvae, ventral views are shown, anterior to the left. (A) Type 1 larvae (blue) display a wild-type morphology, all
cartilage elements are present and well shapped. (B) Type 2 larvae (pink) lack ceratobranchials and have mis-shaped Meckel’s cartilage,
palatoquadrate, ceratohyal and hyosymplectic. (C) Type 3 larvae (green) display a complete absence of viscerocranium and a reduction of the anterior
neurocranium. (D,E) Graphs representing the proportions of the three types of larvae after the indicated treatments. (D) Treatment with the BMP
inhibitor dorsomorphin (200 mM) most severely affects head cartilage between 29 and 45 hpf; (DMSO) dimethylsulfoxide. (E) Heat shock treatment of
(hsp70l:dnBmpr-GFP)w30 transgenic embryos between 27 hpf and 37 hpf most severely affects pharyngeal cartilage development. (F–H) In situ
hybridization for runx2b expression at 48 hpf, lateral views, anterior to the left, scale bars 100 mm. (F) Type 1 embryos (orange) have a normal runx2b
expression pattern in all pharyngeal cartilage precursor cells, cleithrum and ethmoid plate. (G) Type 2 embryos (purple), compared to type 1 embryos,
only express runx2b in cleithrum and weakly in the ethmoid plate. (H) Graph representing the proportions of the two types of larvae after the
indicated treatments. Dorsomorphin treatment of wt embryos and heat shock treatment of (hsp70l:dnBmpr-GFP)w30 between 27 hpf and 37 hpf
decreases runx2b expression in pharyngeal cartilage, but not in the cleithrum. (DMSO) dimethylsulfoxide, (Tg+) Transgene expressing embryo, (Tg-)
Transgene non-expressing siblings, (HS) heat shock. Meckel’s cartilage (m), palatoquadrate (pq), ceratohyal (ch) and hyosymplectic (hs),
ceratobranchials 1 to 5 (cb1-5).
doi:10.1371/journal.pone.0050140.g009
Figure 10. Bmp signaling is down-regulated in egr1 morphants. Pharyngeal cartilage precursor cells were visualized by immunohistochem-
istry using anti-GFP antibodies (green) in fli-GFP embryos. Activity of the BMP signaling pathway was assessed using antibodies against phospho-
Smad1/5/8 (red) in 32 hpf embryos. Ventral view of pharyngeal arches, scale bar 40 mm. (A–F) Pharyngeal cartilage precursor cells were visualized by
immunohistochemistry using anti-GFP antibodies (green) in fli1-GFP embryos. Activity of the BMP signaling pathway was assessed using antibodies
against phospho-Smad1/5/8 (red) in 32 hpf embryos. Ventral view of pharyngeal arches, scale bar 40 mm. (A,B,C) 4 ng MOcon injected embryos, (D, E,
F) 4 ng MOegr1 spl injected embryos. fli1-GFP embryos express the GFP transgene in cartilage precursors and endothelial cells in control (A) and in
egr1 morphants (D). In contrast, phospho-Smad1/5/8 is is clearly down regulated in egr1 morphants (E) compared to control embryos (B). (C,F)
Overlay images of the two anti-body signals clearly show that phospho-Smad1/5/8 is present in GFP-epressing cartilage precursor cells in control
embryos (C), while no colocalization is observed in egr1 morphants (F). (a1) first arch, (a2) second arch, (a3) third arch, (a4) fourth arch, (bv) blood
vessel.
doi:10.1371/journal.pone.0050140.g010
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results establish a regulatory cascade where Runx3 activates
expression of Egr1, which itself then activates sox9b transcription.
This cascade is not required for pharyngeal endoderm formation
or the survival of pharyngeal endodermal cells, as was previously
shown for Runx3 morphants [46]. We similarly confirmed that in
egr1 or runx3 morphants or sox9b mutants, expression of the
endodermal markers nkx2.3 and sox17 is not altered compared to
controls. In conclusion, we describe a regulatory cascade that
operates mainly in the pharyngeal endoderm and controls
expression of runx2b in cartilage mesenchyme as well as cartilage
differentiation and morphogenesis. This control exerted by
endodermal transcription factors is obviously mediated by an
extracellular signaling pathway that remains to be described.
Endodermal Signaling Controls the BMP Pathway in
Cartilage Precursor Cells
One of the signaling pathways involved in cartilage and bone
formation is the TGFß/BMP pathway [12]. BMP ligands bind to
their transmembrane receptor complex, consisting of a type I and
a type II receptor, to induce phosphorylation of the type I
receptor. The activated receptor (Alk1, 2, 3 or 6) then
phosphorylates Smad1, 5 and/or 8 which in turn associate with
their common partner, Smad4 to migrate into the nucleus and
regulate target genes [61]. Craniofacial defects were reported in
conditional knock-out mice lacking BMP type I receptor Alk2 [62]
or Smad4 [63] in cNCC, or in transgenic mice expressing the
antagonistic Smad7 in cNCC cells [64]. In zebrafish, several
members of the BMP ligand family, such as Bmp2a, Bmp2b,
Bmp4, Bmp5 and Bmp7 were shown to be secreted in the
pharyngeal region [12,65,66] and their importance for head
cartilage development was shown [67]. Recently, BMPs were
shown to promote ventral fates of the craniofacial skeleton in
zebrafish [14]. Based on our previous experiments, we therefore
tested the involvement of the BMP pathway in cartilage formation
by inhibiting BMP signaling at stages beyond 24 hpf. Treatment
with the specific inhibitor dorsomorphin [60] revealed that the
importance of BMP signaling for visceral cartilage formation and
runx2b expression increases after 24 hpf and is most crucial during
the period between 27–37 hpf. This result was confirmed by
inducing the expression of a dominant-negative Bmp receptor [45]
at 29 hpf. This period coincides with the time of onset of runx3
[46], egr1 and sox9b gene expression in pharyngeal endoderm.
When we tested the expression of various extracellular signaling
molecules (Shh, Fgf3, Fgf8, Bmps) in egr1 morphants, we did not
detect any decrease of expression for any of these genes. During
development, many processes require inhibition of BMP signaling
by secreted BMP antagonists [56,59,68,69]. Follistatin was first
described as a polypeptide inhibiting the release of follicle
stimulating hormone in the pituitary [70]. Since then, its
involvement in ovarian development and function and its
antagonism to members of the TGFß/BMP family has been
extensively studied [56,71,72]. The function of Follistatin as BMP
antagonist in skeletal development has also been described
[56,69,73]. We observed a strongly increased expression of
follistatin a (fsta) in the pharyngeal region at 48 hpf in egr1
morphants. Such a strong over-expression of Follistatin A would
obviously lead to a perturbation of BMP signaling in the entire
pharyngeal region and cause defects similar to the BMP inhibition
experiments discussed above. Indeed, when we tested activation of
the BMP pathway using antibodies against phospho-Smad1/5/8,
we observed that egr1 knock-down dramatically reduces BMP
signaling in the pharyngeal region. Pathway activation was
abolished not only in the post-migratory cNCC clusters, but also
in the neighboring tissues, potentially causing additional perturba-
tions in skeletal morphogenesis.
Clearly, the function of BMP signaling in craniofacial de-
velopment is conserved in vertebrates, including mouse and
human, and the importance of antagonists such as Follistatin is
also well documented. Different threshold levels of Bmp4 were
shown in mouse to regulate various genes involved in craniofacial
skeletal morphogenesis [74]. Conservation of the endodermal
function of Sox9b is more difficult to assess due to the fact that the
diverging functions of zebrafish Sox9a and Sox9b are covered by
their single mammalian ortholog Sox9. It is however interesting to
note that an increased expression of Follistatin was observed in
male gonads of Sox9 knock out mice [75], suggesting a possible
repressive function similar to that described here.
Taken together, our results indicate that the Runx3/Egr1/
Sox9b regulatory cascade is active in pharyngeal endoderm after
24 hpf to inhibit expression of fsta, which needs to be tightly
controlled so that the Bmp ligands can bind to their respective
receptors located on cartilage precursors cells (Fig.11A,B). In wild
type embryos, BMP signaling also appears to be controlled by the
much weaker expression of follistatin A, as illustrated by the
presence of increased cartilage elements in fsta morphants. BMP
action has to be tightly counterbalanced by inhibitory proteins for
correct morphogenesis of the head skeleton. Although other BMP
antagonists could also contribute to this control, the increased
cartilage observed in fsta morphants attributes an outstanding role
to Follistatin A in this function.
Multiple Roles of the Pharyngeal Endoderm in Cranial
Cartilage Formation
We show that cas mutant embryos lack fsta expression in the
pharyngeal region, as would probably be the case for other
mutants devoid of endoderm. However, instead of presenting an
increase of cartilage as could be expected, cas mutants completely
lack a head skeleton and runx2b expression at 48 hpf ([46], our
own data not shown). This observation obviously reflects the fact
that chondrogenic and osteogenic signals (Bmp, Hh, Fgf) originate
from the endoderm and thus are absent in the mutants, but it also
highlights the importance of maintaining a precise balance of
agonistic and antagonistic activities. It further suggests that
pharyngeal endoderm may be a major source of BMP signaling
in the ventral head region, relative to other surrounding tissues
that are still present in the cas mutants.
Recently, BMP signaling was shown to be involved at earlier
stages (between 17 and 24 hpf) in dorso-ventral patterning by
specifying expression of dorso-ventral markers [14]. Here we show
that inhibition of BMP signaling by dorsomorphin, expression of
a dnBMP receptor or by over-expression of Follistatin A leads to
a complete absence of runx2b expression, similar to complete
absence of endoderm in cas mutants [46]. Thus, in addition to
early dorso-ventral patterning, BMP signaling is required at later
stages for differentiation of all the pharyngeal chondrocytes.
Similarly, Shh signaling from pharyngeal endoderm was recently
shown to be required before 24 hpf for the selective growth and/
or differentiation of anterior cranial cartilage precursor cells,
without affecting dorso-ventral patterning, by inducing fgf8a
expression in oral ectoderm [76]. Ectopic Shha expression by
transgenesis in cas mutant embryos restored fgf8a expression and
formation of the mandibular and hyoid arches. Later pharyngeal
jaw skeleton was only weakly restored, suggesting the requirement
of additional endodermal signals at later stages. According to our
results, members of the BMP family coupled to a finely tuned
control of Follistatin A levels appear as a good candidate for these
signals. The Runx3/Egr1/Sox9b cascade is activated after 24 hpf
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to reduce fsta expression and allow correct BMP signaling that is
required at stages beyond 27 hpf for cartilage formation.
Interestingly, manipulation of the endodermal regulatory
cascade leaves intact the early function of BMP signaling in
dorso-ventral patterning, as indicated by the maintained expres-
sion of the ventral markers hand2 and edn1 at 24 hpf. This is
consistent with the onset of expression after 24 hpf of the
regulators Runx3, Egr1 and Sox9b in pharyngeal endoderm and
with the observed lack of fsta overexpression in egr1 morphants at
24 hpf. An earlier function for control of BMP signaling by
Follistatin A was previously shown in dorso-ventral patterning of
the retina [57]. In this case, fsta expression was shown to be
increased at 13 hpf upon knock-down of the TALE-class home-
odomain transcription factor Meis1, leading to a decrease of BMP
signaling in the optic vesicle. At 19 hpf, fsta expression was highly
increased in meis1 morphants in all its expression domains [57],
suggesting a wider role for Meis1 in enabling BMP signaling at this
stage. Control of fsta expression specifically in the pharyngeal
region at later stages is taken over by the endodermal regulatory
cascade described here.
Multiple Signaling Pathways Converge on Developing
Chondrocytes
Our results indicate that BMP signaling is required in cNCC
cells after their migration to their ventral position in the
pharyngeal arches to induce their differentiation into hypertrophic
chondrocytes, but also to allow their subsequent migration leading
to morphogenesis of the different head cartilages. Additional
extracellular signals will also play a role, such as Fgfs or Hhs. At
24 hpf, cNCC cells express the early differentiation marker sox9a,
whose expression is maintained in pharyngeal cartilage precursor
cells and required for their differentiation [6]. Depletion of the
endodermal regulatory cascade does not affect sox9a expression. In
contrast, the key regulatory gene for chondrogenesis and
osteogenesis, runx2b is dramatically down-regulated in egr1
morphants. Its expression in pharyngeal cartilage precursor cells
normally starts at 34 hpf [46] and was shown to be essential for
chondrocyte and osteoblast differentiation [44,75]. This timing is
consistent with the requirement for fsta down-regulation for
efficient activation by BMP signaling as described here. runx2b
expression is down-regulated despite the normal expression of
sox9a, conversely it is not affected in sox9a mutants [5], indicating
that at least two different pathways are required in chondrocyte
precursor cells for activation of these two genes and, thus for
chondrogenesis and that neither of them can compensate the
function of the other.
Interestingly, inhibition of BMP signaling by increased Follis-
tatin A expression in our experiments led to a decreased
expression of runx2b in presumptive head cartilage, but left nearly
intact its expression in the developing cleithrum, a dermal bone.
Similar observations were made in the sox9a mutants [5,6]. These
observations indicate that both sox9a expression and fsta inhibition
are mainly required for endochondral (replacement) bone
formation.
In conclusion, we show here that a regulatory cascade is active
in pharyngeal endoderm that represses expression of the fsta gene,
thereby allowing the correct activation of BMP signaling in cNCC
cells required for their differentiation and morphogenesis of
pharyngeal and basicranial cartilage. This cascade starts by
increased expression of runx3, followed by activation of egr1
expression and finally sox9b expression in the pharyngeal
endoderm.
Supporting Information
Figure S1 casanova mutants, lacking endoderm, do not
express egr1 at 48 hpf. Single in situ hybridization for egr1 in
casanova mutants. Lateral (A,B) and dorsal (C,D) views, anterior to
the left. Scale bars 100 mm. (A,C) Wild-type or heterozygous cas+/
2 express egr1 in the pharyngeal endoderm (pe). (B,D) Homozy-
gous cas2/2 do not express egr1 in the pharyngeal region, but in
the pectoral fins and in the two hearts of cas2/2 embryos. Pectoral
fin (pf), heart (h).
(TIF)
Figure S2 casanova mutants, lacking endoderm, do not
express sox9b or fsta at 48 hpf. Lateral views of in situ
hybridizations (A–D) with indicated markers, anterior to the left.
Scale bars 100 mm. Homozygous cas2/2 do not express fsta (A,B)
Figure 11. Runx3, Egr1 and Sox9b form a regulatory cascade
required to modulate Bmp-signaling during cranial cartilage
development in zebrafish. Signaling model in wild-type embryos (A)
and in embryos lacking of endodermal regulatory cascade (B). (A) In
wild-type embryos, pharyngeal endoderm expresses a regulatory
cascade composed of three transcription factors, Runx3, Egr1 and
Sox9b, which down-regulates fsta expression that codes for a Bmp
antagonist. This down-regulation of fsta enables Bmp ligands to bind to
their heterodimeric receptor (BmpRI and BmpRII) and induce runx2b
expression in cranial neural crest cells (cNCC). (B) Embryos lacking of
any member of Runx3-Egr1-Sox9b cascade have an over-expression of
fsta, which its coding protein is secreted from the endoderm.
Antagonist Fsta binds to Bmp ligands and inhibit them to bind to
their receptor, having for consequence no Bmp-signaling towards the
cNCC and no runx2b expression.
doi:10.1371/journal.pone.0050140.g011
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nor sox9b (C,D) compared to wild-type or heterozygous cas+/2.
Pharyngeal endoderm (pe), otic vesicle (ov).
(TIF)
Movie S1 Double fluorescent in situ hybridization for
fli1 (Cy3, red) and egr1 (FITC, green) in 47 hpf zebrafish
embryos. Lateral view, anterior to the left, the movie proceeds
from the left side going to the center of the embryo. fli1 is
expressed in cranial neural crest cells (pharyngeal cartilage
precursor cells) and in endothelium. fli1 displays the characteristic
expression pattern in ‘‘stripes’’ of the pharygeal cartilage precursor
cells. egr1 is expressed more inside of the embryo in the pharyngeal
endoderm. fli1 and egr1 mRNAs never colocalize.
(MP4)
Movie S2 Double fluorescent in situ hybridization for
sox9a (Cy3, red) and egr1 (FITC, green) in 72 hpf larvae.
Lateral view, anterior to the right, the movie proceeds from the
right side going to the center of the embryo. sox9a is expressed in
pharyngeal cartilage cells and egr1 is expressed in pharyngeal
endoderm. sox9a and egr1 mRNAs never colocalize and the egr1
expression domains surrounding the sox9a expression domains can
be clearly observed.
(MP4)
Movie S3 Double fluorescent in situ hybridization for
sox9b (Cy3, red) and egr1 (FITC, green) at 72 hpf. Lateral
view, anterior to the right, the movie proceeds from the right side
going to the center of the embryo. sox9b and egr1 are expressed in
pharyngeal endoderm cells and colocalize in the same expression
domains.
(MP4)
Movie S4 Double fluorescent in situ hybridization for
fli1 (Cy3, red) and egr1 (FITC, green) at 4 dpf. Lateral
view, anterior to the right, the movie proceeds from the right side
going to the center of the embryo. fli1 is expressed in pharyngeal
cartilages and in endothelium. Egr1 is expressed in the phrayngeal
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